Cross-validation of a new prognostic index integrating tumor marker decline in patients with relapsed disseminated germ cell tumors

Christophe Massard,H. Huguet,Andrew Kramar,J. Beyer,J. T. Hartmann,Anja Lorch,J.-L. Pico,G. Rosti,J.-P. Droz,Karim Fizazi

Cross-validation of a new prognostic index integrating tumor marker decline in patients with relapsed disseminated germ cell tumors

2009

Christophe Massard
H. Huguet
Andrew Kramar
J. Beyer
J. T. Hartmann
Anja Lorch
J.-L. Pico
G. Rosti
J.-P. Droz
Karim Fizazi

5086 Background: Early serum tumor marker decline during chemotherapy was previously shown to be prognostic for progression-free survival (PFS) and overall survival (OS) in patients with relapsed G...

Keywords:

Germ cell tumors
Tumor marker
Pathology
Medicine
Internal medicine
Chemotherapy
in patient
Oncology
overall survival

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations